Evidence for a dynamic host-parasite relationship in e-negative hepatitis B carriers

Journal of Medical Virology

Volumn 68, Issue 4, 2002, Pages 505-512

  Tedder, Richard S ^a   Ijaz, Samreen ^a   Gilbert, Nicola ^a   Barbara, John A J ^b   Corden, Sally A ^c   Gilson, Richard J C ^a   Boxall, Elizabeth H ^c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

HBV DNA levels; Health care workers; Precore mutants

Indexed keywords

AMINOTRANSFERASE; HEPATITIS B(E) ANTIBODY; VIRUS DNA;

AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; EVALUATION; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HEPATITIS B; HEPATITIS B VIRUS; HOST PARASITE INTERACTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRACTICE GUIDELINE; PREDICTION; PUBLIC HEALTH SERVICE; UNITED KINGDOM; VIREMIA; VIRUS CARRIER; VIRUS DETECTION;

ANTIBODIES, VIRAL; CARRIER STATE; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MALE; MUTATION; POLYMERASE CHAIN REACTION; VIRAL LOAD;

HEPATITIS B VIRUS;

EID: 0036883673     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10241     Document Type: Article

References (20)

1. Alter HJ, Seeff LB, Kaplan PM, McAuliffe VJ, Wright EC, Gerin JL, Purcell RH, Holland PV, Zimmerman HJ. 1976. Type B hepatitis: The infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. N Engl J Med 21: 903-913.
2. Ballard AL, Boxall EH. 1997. Colourimetric point mutation assay: For detection of precore mutants of hepatitis B. J Virol Methods 67: 143-152.
3. Brunetto MR, Giarin MM, Oliveri F, Chiagerge E, Baldi M, Alfarano A, Serra A, Saracco G, Verme G, Will H, Bonino F. 1991. Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci USA 88:4186-4190.
4. Cabrerizo M, Bartolomé J, Inigo ER, López-Alcorocho JM, Cotonat T, Carreño V. 1998. Analysis of the hepatitis B virus precore and ORFX sequences in patients with antibody to hepatitis Be antigen with and without normal ALT levels. J Med Virol 56:294-299.
5. Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, Thomas HC. 1989. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis infection. Lancet 2:588-591.
6. Corden S, Ballard AL, Ijaz S, Barbara JAJ, Gilbert N, Gilson RJC, Boxall EH, Tedder RS. 2002. HBV DNA Levels and Transmission of Hepatitis B by Health Care Workers. (in press.)
7. Health Service Guidelines: HSG(93)40. 1993. Protecting Health Care Workers and Patients from Hepatitis B. London: National Health Service.
8. Health Service Circular. HSC 2000/020.2000. Hepatitis B Infected Health Care Workers. London: National Health Service.
9. Fujiwara K, Yokosuka O, Ehata T, Chuang W-L, Imazeki F, Saisho H, Omata M. 1998. The two different states of hepatitis B virus DNA in asymptomatic carriers. HBe-antigen-positive versus anti-HBe-positive asymptomatic carriers. Dig Dis Sci 43:368-376.
10. Hawkins AE, Gilson RJC, Beath SV, Boxall EH, Kelley DA, Tedder RS, Weller IVD. 1994. Novel application of a point mutation assay; evidence for transmission of hepatitis B viruses with precore mutations and their detection in infants with fulminant hepatitis B. J Med Virol 44:13-21.
11. Heptonstall J, and the Incident Investigation Teams. 1997. Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen. N Engl J Med 336:178-184.
12. Kessler HH, Preminger S, Stelzl E, Daghofer E, Santner BI, Marth E, Lackner H, Stauber RE. 2000. Identification of different states of hepatitis B virus infection with a quantitative PCR assay. Clin Diagn Lab Immunol 7:298-300.
13. Knöll A, Rohrhofer A, Kochanowski B, Wurm E-M, Jilg W. 1999. Prevalence of precore mutants in anti-HBe-positive hepatitis B virus carriers in Germany. J Med Virol 59:14-18.
14. Lai ME, Solinas A, Mazzoleni AP, Deplano A, Farci P, Lisci V, Porru A, Tocca A, Balestrieri A. 1994. The role of precore hepatitis B virus mutants on the long-term outcome of chronic hepatitis B virus hepatitis. A longitudinal study. J Hepatitis 20:773-781.
15. Lindh M, Gustavson C, Mardberg K, Norkrans G, Dhillon AP, Horal P. 1998. Mutation of nucleotide 1,762 in the core promoter region during hepatitis B e seroconversion and its relation to liver damage in hepatitis Be antigen carriers. J Med Virol 55:185-190.
16. Maini MK, Boni C, Lee CK, Larrubia JR, Reignat S, Ogg GS, King AS, Herberg J, Gilson R, Alisa A, Williams R, Vergani D, Naoumov NV, Ferrari C, Bertoletti A. 2000. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 191:1269-1280.
17. Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y. 1976. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 294:746-749.
18. Okamoto H, Tsuda F, Akahane Y, Sugai Y, Yishiba M, Moriyama K, Tanaka T, Miyakawa Y, Mayumi M. 1994. Hepatitis B virus with mutations in the core promotor for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol 68:8102-8110.
19. Scaglioni PP, Melegari M, Wands JR. 1997. Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame. Virology 233:374-381.
20. Sundkvist T, Hamilton GR, Rimmer D, Evans BG, Teo CG. 1998. Fatal outcome of transmission of hepatitis B from an e antigen negative surgeon. Commun Dis Public Health 1:48-50.